HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Stephane De Wit Selected Research
Stephane De Wit Research Topics
Disease
9
Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 03/2009
7
Acquired Immunodeficiency Syndrome (AIDS)
11/2021 - 01/2011
7
Myocardial Infarction
01/2013 - 11/2003
5
Insulin Resistance
01/2023 - 06/2008
5
Lipodystrophy
01/2023 - 01/2005
5
Infections
01/2023 - 10/2008
4
Hypertension (High Blood Pressure)
11/2021 - 01/2005
4
HIV Infections (HIV Infection)
11/2015 - 10/2008
3
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2023 - 03/2009
3
Inflammation (Inflammations)
01/2023 - 01/2011
3
Hepatitis B
12/2014 - 10/2008
2
Thrombophilia
01/2023 - 12/2021
2
Body Weight (Weight, Body)
01/2023 - 07/2010
2
Heart Failure
01/2023 - 12/2021
2
Weight Gain
12/2021 - 11/2021
2
Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2021 - 09/2010
2
Chronic Renal Insufficiency
10/2019 - 11/2017
2
Stroke (Strokes)
08/2019 - 01/2013
2
Coinfection
12/2014 - 04/2012
2
Dyslipidemias (Dyslipidemia)
10/2012 - 04/2007
2
Diabetes Mellitus
10/2012 - 02/2009
2
Coronary Disease (Coronary Heart Disease)
02/2009 - 04/2008
1
COVID-19
05/2024
1
Severe Acute Respiratory Syndrome
05/2024
1
Shock
01/2019
1
Fibrosis (Cirrhosis)
01/2019
1
Drug Hypersensitivity Syndrome
01/2018
1
Overweight
10/2016
1
Osteoporosis
11/2015
1
Metabolic Bone Diseases (Osteopenia)
11/2015
1
Hypersensitivity (Allergy)
01/2015
1
Type 2 Diabetes Mellitus (MODY)
12/2014
1
Prostatic Neoplasms (Prostate Cancer)
01/2014
1
Lung Neoplasms (Lung Cancer)
10/2013
1
Neoplasms (Cancer)
10/2013
1
Hypercholesterolemia
07/2013
1
Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2013
1
Duodenal Ulcer (Curling's Ulcer)
04/2012
1
Thrombosis (Thrombus)
10/2008
1
Liver Diseases (Liver Disease)
08/2006
Drug/Important Bio-Agent (IBA)
9
Anti-HIV Agents (AIDS Drugs)
IBA
10/2019 - 02/2009
5
Lipids
IBA
01/2023 - 04/2007
4
Protease Inhibitors (Protease Inhibitor)
IBA
01/2023 - 01/2005
4
Biomarkers (Surrogate Marker)
IBA
01/2023 - 10/2008
4
Cholesterol
IBA
10/2016 - 11/2003
4
abacavir (Ziagen)
FDA Link
11/2015 - 04/2008
3
dolutegravir
IBA
01/2023 - 01/2018
3
Raltegravir Potassium
FDA Link
11/2021 - 11/2015
3
RNA (Ribonucleic Acid)
IBA
01/2021 - 10/2008
3
Triglycerides (Triacylglycerol)
IBA
07/2011 - 11/2003
3
Reverse Transcriptase Inhibitors
IBA
04/2008 - 01/2005
2
Adiponectin
IBA
01/2023 - 12/2021
2
tenofovir alafenamide
IBA
11/2021 - 11/2015
2
Creatinine
IBA
11/2015 - 07/2010
2
HDL Cholesterol
IBA
07/2011 - 03/2009
2
Nucleosides
IBA
04/2008 - 01/2005
1
cilgavimab and tixagevimab drug combination
IBA
05/2024
1
tixagevimab
IBA
05/2024
1
cilgavimab
IBA
05/2024
1
Enzymes
IBA
01/2023
1
drug combination tenofovir alafenamide emtricitabine bictegravir
IBA
01/2023
1
Lipopolysaccharide Receptors
IBA
12/2021
1
Hepatitis B Surface Antigens (HBsAg)
FDA Link
12/2019
1
Hepatitis B e Antigens
IBA
12/2019
1
Transaminases (Aminotransferases)
IBA
01/2019
1
Alanine Transaminase (SGPT)
IBA
01/2019
1
Serum Albumin
IBA
01/2018
1
Surface Antigens (Surface Antigen)
IBA
11/2015
1
Steroids
IBA
11/2015
1
Tenofovir (Viread)
FDA Link
11/2015
1
HLA-B57 antigen
IBA
01/2015
1
C-Reactive Protein
IBA
12/2014
1
Interleukin-6 (Interleukin 6)
IBA
12/2014
1
Prostate-Specific Antigen (Semenogelase)
IBA
01/2014
1
N-acetoacetyl-N-deacetylcolchicine
IBA
10/2013
1
Lopinavir
FDA Link
07/2013
1
Ritonavir (Norvir)
FDA Link
01/2013
1
Atazanavir Sulfate (Reyataz)
FDA Link
01/2013
1
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
04/2012
1
Proton Pump Inhibitors
IBA
04/2012
1
Macrolides
IBA
04/2012
1
Anti-Bacterial Agents (Antibiotics)
IBA
04/2012
1
fibrin fragment D (D-dimer)
IBA
01/2011
1
insulin receptor-related receptor (IRR)
IBA
01/2011
1
Thromboplastin (Tissue Factor)
IBA
10/2008
1
Thymidine
IBA
06/2008
1
Lamivudine (Epivir)
FDA Link
04/2008
1
Zidovudine (Retrovir)
FDA Link
Generic
04/2008
1
Stavudine (Zerit)
FDA Link
Generic
04/2008
1
Didanosine (Videx)
FDA Link
Generic
04/2008
1
Antihypertensive Agents (Antihypertensives)
IBA
01/2005
Therapy/Procedure
9
Therapeutics
11/2021 - 10/2008
6
Highly Active Antiretroviral Therapy (HAART)
10/2012 - 11/2003
5
Art Therapy
01/2021 - 01/2011
1
Ambulatory Care (Outpatient Care)
01/2013